Corrigendum: Reliable estimation of CD8 T cell inhibition of in vitro HIV-1 replication

Front Immunol. 2023 Jan 3:13:1104661. doi: 10.3389/fimmu.2022.1104661. eCollection 2022.

Yinyan Xu¹, Ann Marie Weideman^{2

3}, Maria Abad-Fernandez¹, Katie R Mollan^{3

4}, Sallay Kallon¹, Shahryar Samir¹, Joanna A Warren¹, Genevieve Clutton¹, Nadia R Roan^{5

6}, Adaora A Adimora^{3

4

7}, Nancie Archin⁷, JoAnn Kuruc⁷, Cynthia Gay⁷, Michael G Hudgens^{2

3}, Nilu Goonetilleke^{1

1}

¹ Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.
² Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
³ Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
⁴ Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, United States.
⁵ Department of Urology, University of California San Francisco, San Francisco, CA, United States.
⁶ Gladstone Institute of Virology and Immunology, San Francisco, CA, United States.
⁷ School of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2021.666991.].

Keywords: CD4; CD8; HIV; JRCSF; ROC; T-cell; VIA; p24.